Alexis M. Schneider

Statistics

Publications

Citations

748

H-Index

Active since

2018

Affiliations

Massachusetts Institute of Technology(Current)

Harvard University

Massachusetts General Hospital

Broad Institute

Dana-Farber Cancer Institute

Alexis M. Schneider is an author at Massachusetts Institute of Technology specializing in infectious diseases, sars-cov-2 infection, and life sciences.

ORCID

Publications per year

2018–2023

Publications

Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions

Michael R. Filbin, Arnav Mehta, Alexis M. Schneider et al. · Cell Reports Medicine · 2021 · 309 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Targeting TBK1 to overcome resistance to cancer immunotherapy

Yi Sun, Or‐Yam Revach, Seth Anderson et al. · Nature · 2023 · 167 citations · Full text

Medicine, Cancer Biology, Oncology +12

SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes

Yijia Li, Alexis M. Schneider, Arnav Mehta et al. · Journal of Clinical Investigation · 2021 · 122 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +12

Optogenetic Peripheral Nerve Immunogenicity

Benjamin E. Maimon, Maurizio Diaz, Emilie C. M. Revol et al. · Scientific Reports · 2018 · 80 citations · Full text

Life Sciences, Neurobiology, Neuroscience +15

Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients

Michael R. Filbin, Arnav Mehta, Alexis M. Schneider et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 49 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

1–5 of 7